VCAM1 and Sepsis: In parallel, increased serum levels of VCAM-1 were described in COVID-19 patients with distinct severity under dexamethasone treatment in correlation with classic sepsis biomarkers soluble urokinase-type plasminogen activator receptor and presepsin [52].